Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-16-113791

Director sold 5,000 shares at $4.34 ($21,700)

  • Director acquired 6,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lawrence Thomas R Director 2016-03-17 Sale −5,000 $4.34 $21,700 45,381 D
Lawrence Thomas R Director 2016-04-06 Grant or award +6,000 $4.34 $26,040 51,381 D
Open-market sales · 5,000 sh · avg $4.34 · $21,700
Loading xslF345X03/doc4.xml…